INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Summary of the facts of the SARS-CoV-2 injections scam

Summary of the facts of the SARS-CoV-2 injections scam

Fact not fiction

Hedley Rees's avatar
Hedley Rees
Aug 29, 2023
∙ Paid
10

Share this post

INSIDE PHARMA
INSIDE PHARMA
Summary of the facts of the SARS-CoV-2 injections scam
5
Share

Fact not Fiction

What people don’t know is that I consulted to the company that developed and manufactured the AstraZeneca adenovirus ‘vaccine’, Oxford Biomedica, in 2013. Then, they were developing and manufacturing their lentiviral vector gene therapy product for Novartis, Kymriah, approved by FDA August 2017. It has a warning on the label on neurological toxicities and Cytokine Release Syndrome.

A research body connected with UKs Office for Life Sciences paid me a small fee to find a company (Oxford Biomedica) and consult to them, which resulted in Oxford Biomedica gaining a $9 million Government Grant for the Advanced Manufacturing Supply Chain initiative. The Office for Life Sciences got quite excited

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share